Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 18, 2017 - Issue 1
Submit an article Journal homepage
845
Views
8
CrossRef citations to date
0
Altmetric
Original Research

Effect of 24-week treatment with ipragliflozin on proinsulin/C-peptide ratio in Japanese patients with type 2 diabetes

Yoshio NagaiDivision of Metabolism and Endocrinology, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, JapanCorrespondence[email protected]
View further author information
,
Akio OhtaDivision of Metabolism and Endocrinology, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, JapanView further author information
,
Yukiyoshi SadaDivision of Metabolism and Endocrinology, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, JapanView further author information
,
Hiroyuki KatoDivision of Metabolism and Endocrinology, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, JapanView further author information
&
Yasushi TanakaDivision of Metabolism and Endocrinology, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, JapanView further author information
Pages 13-17 | Received 17 Oct 2016, Accepted 11 Nov 2016, Published online: 21 Nov 2016

Citations (8)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Takahiro Takase, Akinobu Nakamura, Chiho Yamamoto, Tatsuya Atsumi & Hideaki Miyoshi. (2018) Improvement in the proinsulin/C-peptide ratio during treatment with ipragliflozin in Japanese patients with type 2 diabetes mellitus. Expert Opinion on Pharmacotherapy 19:7, pages 631-632.
Read now

Articles from other publishers (7)

Akinobu Nakamura. (2022) Effects of Sodium-Glucose Co-Transporter-2 Inhibitors on Pancreatic β-Cell Mass and Function. International Journal of Molecular Sciences 23:9, pages 5104.
Crossref
Кушнарёва Н. Н., Зиныч Л. В., Ковальчук А. В., Прибила О. В. & Шишкань-Шишова Е. А.. (2021) ОЦЕНКА ВЛИЯНИЯ ТЕРАПИИ ИНКРЕТИНОМИМЕТИКАМИ И ГЛИФЛОЗИНАМИ НА ФУНКЦИЮ АЛЬФА И БЕТА-КЛЕТОК ПОДЖЕЛУДОЧНОЙ ЖЕЛЕЗЫ У ПАЦИЕНТОВ С СД 2 ТИПА. World Science:3(64).
Crossref
Francesco Giorgino, Jiten Vora, Peter Fenici & Anna Solini. (2020) Renoprotection with SGLT2 inhibitors in type 2 diabetes over a spectrum of cardiovascular and renal risk. Cardiovascular Diabetology 19:1.
Crossref
Kazumi Mori‐Anai, Yoshihiko Tashima, Tomohisa Nakada, Yoshinobu Nakamaru, Takayuki Takahata & Ryuta Saito. (2020) Mechanistic evaluation of the effect of sodium‐dependent glucose transporter 2 inhibitors on delayed glucose absorption in patients with type 2 diabetes mellitus using a quantitative systems pharmacology model of human systemic glucose dynamics. Biopharmaceutics & Drug Disposition 41:8-9, pages 352-366.
Crossref
André J. Scheen. (2020) Glucotoxicité et lipotoxicité dans le diabète de type 2 : comment protéger la cellule β ?. Médecine des Maladies Métaboliques 14:6, pages 549-557.
Crossref
Gee-Hong Kuo, Micheal D. Gaul, Yin Liang, June Z. Xu, Fuyong Du, Pamela Hornby, Guozhang Xu, Jenson Qi, Nathaniel Wallace, Seunghun Lee, Eugene Grant, William V. Murray & Keith Demarest. (2018) Synthesis and biological evaluation of benzocyclobutane-C-glycosides as potent and orally active SGLT1/SGLT2 dual inhibitors. Bioorganic & Medicinal Chemistry Letters 28:7, pages 1182-1187.
Crossref
Atsunori Kashiwagi, Taishi Sakatani, Ichiro Nakamura, Noriko Akiyama, Kenichi Kazuta, Eiji Ueyama, Hideyuki Takahashi & Yoshinori Kosakai. (2018) Improved cardiometabolic risk factors in Japanese patients with type 2 diabetes treated with ipragliflozin: a pooled analysis of six randomized, placebo-controlled trials. Endocrine Journal 65:7, pages 693-705.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.